Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGLT2 Inhibitors in Primary Nephrotic Syndrome
NCT07214818Phase 3Recruiting
- Sponsor
- Mansoura University
- Start
- Nov 2025
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapagliflozin, empagliflozin, sponsored by Mansoura University. Started Nov 2025; status: recruiting.
02
Drugs
dapagliflozinempagliflozin
Beyond the preview
Go deeper on NCT07214818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07214818.